The Challenge of CMC Regulatory Compliance for Biopharmaceuticals by John Geigert.
This book since first published in 2004 has been a major resource providing insights and practical guidance for the CMC teams to develop an acceptable cost-effective, risk-based CMC regulatory compliance strategy for biopharmaceuticals (recombinant proteins, monoclonal antibodies, genetically engine...
Full description
Saved in: